COVID-19 outcomes in hospitalized patients with underlying connective tissue disease-related interstitial lung disease vs. idiopathic interstitial pneumonia: a nationwide analysis 2019-2020
ARP Rheumatology · 2025
DOI: 10.63032/axep3539 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift ARP Rheumatology, 2025. Verfasst von Husam El Sharu und 6 weiteren Autor:innen. Beteiligte Einrichtung: East Carolina University. Hauptthemen laut MEDLINE: COVID-19, Connective Tissue Diseases, Lung Diseases, Interstitial, Idiopathic Interstitial Pneumonias.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- East Carolina University.
- The University of Oklahoma.
- University of Alabama at Birmingham.
- King Hussein Cancer Center.
- University Hospitals.
Zitieren
APA
El Sharu, H., Haddaden, M., Singh, S., Noboa, M. R., Mubaydeen, T., Alqalyoobie, S., & Sabha, M. (2025). COVID-19 outcomes in hospitalized patients with underlying connective tissue disease-related interstitial lung disease vs. idiopathic interstitial pneumonia: a nationwide analysis 2019-2020. ARP Rheumatology. https://doi.org/10.63032/axep3539
Vancouver
El Sharu H, Haddaden M, Singh S, Noboa MR, Mubaydeen T, Alqalyoobie S, et al. COVID-19 outcomes in hospitalized patients with underlying connective tissue disease-related interstitial lung disease vs. idiopathic interstitial pneumonia: a nationwide analysis 2019-2020. ARP Rheumatology. 2025. doi:10.63032/axep3539
BibTeX
@article{ElSharu2025,
author = {El Sharu, Husam and Haddaden, Metri and Singh, Sukhvir and Noboa, Maria Romero and Mubaydeen, Teeba and Alqalyoobie, Shehabaldin and Sabha, Marwa},
title = {COVID-19 outcomes in hospitalized patients with underlying connective tissue disease-related interstitial lung disease vs. idiopathic interstitial pneumonia: a nationwide analysis 2019-2020},
journal = {ARP Rheumatology},
year = {2025},
doi = {10.63032/axep3539}
}
EUVIMED